High rates of central obesity and sarcopenia in CKD irrespective of renal replacement therapy - an observational cross-sectional study

• Published in: BMC nephrology 2018-10, Vol.19 (1), p.259-259, Article 259
• Main Authors: Dierkes, Jutta, Dahl, Helene, Lervaag Welland, Natasha, Sandnes, Kristina, Sæle, Kristin, Sekse, Ingegjerd, Marti, Hans-Peter
• Format: Article
• Language: English
• Subjects: Aging; Body composition; Body fat; Body mass index; Body weight; Cardiovascular disease; Cross-sectional studies; Diabetes; Diabetes mellitus; Dietary intake; Energy; ESRD; Health risk assessment; Hemodialysis; Kidney diseases; Kidney transplantation; Metabolism; Mortality; Nephrology; Nutritional status; Obesity; Overweight; Patients; Peritoneal dialysis; Proteins; Renal disease; Renal function; Renal replacement therapy; Sarcopenia; Transplants & implants; Weight control
• ISSN: 1471-2369; 1471-2369
• DOI: 10.1186/s12882-018-1055-6

Poor nutritional status of patients with renal disease has been associated with worsening of renal function and poor health outcomes. Simply measuring weight and height for calculation of the body mass index does however not capture the true picture of nutritional status in these patients. Therefore, we measured nutritional status by BMI, body composition, waist circumference, dietary intake and nutritional screening in three groups of renal patients. Patients with chronic kidney disease not on renal replacement therapy (CKD stages 3-5, n = 112), after renal transplantation (n = 72) and patients treated with hemodialysis (n = 24) were recruited in a tertiary hospital in Bergen, Norway in a cross-sectional observational study. Dietary intake was assessed by a single 24 h recall. All patients underwent nutritional screening, anthropometric measurements, body composition measurement andfunctional measurements (hand grip strength). The prevalence of overweight and obesity, central obesity, sarcopenia, sarcopenic obesity and nutritional risk was calculated. Central obesity and sarcopenia were present in 49% and 35% of patients, respectively. 49% of patients with central obesity were normal weight or overweight according to their BMI. Factors associated with central obesity were a diagnosis of diabetes and increased fat mass, while factors associated with sarcopenia were age, female gender, number of medications. An increase in the BMI was associated with lower risk for sarcopenia. Central obesity and sarcopenia were present in renal patients at all disease stages. More attention to these unfavorable nutritional states is warranted in these patients.